在等待肝移植的儿童的管理:萨科佩尼亚,胆固醇症和超越
Julia M Boster1, Katie R Conover1, Sarah A Taylor1
1Department of Pediatrics, Digestive Health Institute, Children's Hospital Colorado and University of Colorado School of Medicine, Aurora, Colorado, USA.
Pediatric transplantation
|October 8, 2025
概括
肌肉消耗性疾病 - - 肉症是肝移植的危险因素,但儿科数据有限. 了解患有肝脏疾病的儿童的肉症对于更好的结果至关重要.
科学领域:
- 儿科胃肠病学和肝病学
- 移植医学 移植医学
- 营养科学 营养科学
背景情况:
- 麻症是肝移植中不良结果的新兴风险因素.
- 有限的数据存在于儿科特定的萨科佩尼亚结果,定义和评估.
- 从营养不良和虚弱区分萨尔科佩尼亚是临床实践的关键.
研究的目的:
- 审查目前对小儿肝脏疾病患者进行移植的萨尔科佩尼亚的理解.
- 为了确定有关这群人群中萨尔科佩尼亚的识别,评估和治疗的知识差距.
- 突出未来的研究重点在胆固醇性肝病中治疗儿科肉症.
主要方法:
- 文献综述,重点关注儿科肉症和肝移植.
- 对儿科和成人慢性肝病中sarcopenia机制的现有数据的分析.
- 综合关于儿童营养评估挑战的信息.
主要成果:
- 在定义和评估儿科麻症方面存在显著的知识差距.
- 与营养不良和虚弱重叠的特征使儿童的诊断复杂化.
- 了解萨科佩尼亚对儿科肝移植结果的影响需要进一步的研究.
结论:
- 对于儿科萨尔科佩尼亚的标准化定义和功能性评估有着至关重要的需要.
- 进一步的研究对于阐明sarcopenia的机制和对儿科肝病和移植的影响至关重要.
- 解决这些差距将改善临床管理和患者的治疗结果.
相关概念视频
Kidney Transplant III: Nursing Management
317
Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
317
Kidney Transplant II: Surgical Procedure
307
Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
307
Kidney Transplant I: Introduction
340
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
340
Esophageal Varices-II: Clinical Features and Management
368
Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
368
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
180
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
180
Pharmacokinetics in Pediatric Patients: Drug Metabolism
192
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
192


